Amends the Lanham Trade-Mark Act to state that it is not a false designation of origin or a false description or representation whenever a drug in tablet form is the same size, color, and shape as a tablet of another drug.
Introduced in House
Introduced in House
Referred to House Committee on The Judiciary.
Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line